How much should psychedelics researchers disclose about their personal use of psilocybin, ketamine, and other drugs?
Anonymous survey with optional confidential interviews will document how practitioners facilitate MDMA-assisted couples therapyFindings to inform ...
Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with ...
Rick Doblin had come to believe that psychedelic experiences are the "common core" of all religions, and he wanted to test this thesis. In February 1984, the 31-year-old college student living off a ...
Two-thirds of people who underwent psilocybin-assisted therapy remained free from depression five years later, according to recent research that offers the first long-term glimpse into the lasting ...
Psychedelic therapy isn’t just about the drug; it’s about the dose, too. Here's why the overlooked middle ground may matter ...
WEST PALM BEACH, Fla. (CBS12) — If you are someone who suffers from common mental health conditions, new research involving the use of psychedelics could be the key to treating an array of disorders ...
Believers in the healing potential of the mind-altering drugs thought RFK Jr. was the answer to their prayers. They’re still ...
In a comprehensive Genomic Press Interview, Emory University MD candidate Fayzan Rab shares insights into his pioneering research on the economic and public health implications of psychedelic therapy ...
Every day in America, we lose on average from 17 to 44 veterans to suicide — more than the average daily casualties during active military conflicts in Vietnam, Iraq and Afghanistan combined. As a ...
For Tim Ferriss, the best-selling author, podcaster, and investor, the decision to devote his philanthropy to research into psychedelic drugs is built on a solid foundation of peer-reviewed science.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results